nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—Tenofovir—NME2—ovarian cancer	0.0143	0.512	CrCbGaD
Adenosine—ADA—myometrium—ovarian cancer	0.0138	0.0445	CbGeAlD
Adenosine—SLC28A3—bone marrow—ovarian cancer	0.0116	0.0375	CbGeAlD
Adenosine—ADK—myometrium—ovarian cancer	0.0113	0.0363	CbGeAlD
Adenosine—SLC28A3—female gonad—ovarian cancer	0.0112	0.0362	CbGeAlD
Adenosine—ADORA2B—decidua—ovarian cancer	0.0112	0.036	CbGeAlD
Adenosine—DPP4—embryo—ovarian cancer	0.0105	0.0339	CbGeAlD
Adenosine—ADA—decidua—ovarian cancer	0.0102	0.033	CbGeAlD
Adenosine—ADK—uterine cervix—ovarian cancer	0.00877	0.0283	CbGeAlD
Adenosine—DPP4—epithelium—ovarian cancer	0.00857	0.0276	CbGeAlD
Adenosine—DPP4—uterine cervix—ovarian cancer	0.0085	0.0274	CbGeAlD
Adenosine—ADK—decidua—ovarian cancer	0.00835	0.0269	CbGeAlD
Adenosine—ADORA2A—gonad—ovarian cancer	0.00819	0.0264	CbGeAlD
Adenosine—DPP4—decidua—ovarian cancer	0.0081	0.0261	CbGeAlD
Adenosine—ADA—female reproductive system—ovarian cancer	0.00804	0.0259	CbGeAlD
Adenosine—ADORA2B—vagina—ovarian cancer	0.00795	0.0256	CbGeAlD
Adenosine—ADK—endometrium—ovarian cancer	0.00793	0.0256	CbGeAlD
Adenosine—DPP4—endometrium—ovarian cancer	0.00769	0.0248	CbGeAlD
Adenosine—ADA—bone marrow—ovarian cancer	0.00759	0.0245	CbGeAlD
Adenosine—ADK—gonad—ovarian cancer	0.00736	0.0237	CbGeAlD
Adenosine—ADORA2A—female reproductive system—ovarian cancer	0.00732	0.0236	CbGeAlD
Adenosine—ADA—vagina—ovarian cancer	0.00727	0.0234	CbGeAlD
Adenosine—ADORA2B—testis—ovarian cancer	0.0071	0.0229	CbGeAlD
Adenosine—DPP4—uterus—ovarian cancer	0.00709	0.0228	CbGeAlD
Adenosine—Cladribine—NR5A1—ovarian cancer	0.00686	0.246	CrCbGaD
Adenosine—ADK—female reproductive system—ovarian cancer	0.00657	0.0212	CbGeAlD
Adenosine—ADA—testis—ovarian cancer	0.00649	0.0209	CbGeAlD
Adenosine—DPP4—female reproductive system—ovarian cancer	0.00637	0.0205	CbGeAlD
Adenosine—ADORA1—female reproductive system—ovarian cancer	0.00632	0.0204	CbGeAlD
Adenosine—ADK—bone marrow—ovarian cancer	0.0062	0.02	CbGeAlD
Adenosine—DPP4—bone marrow—ovarian cancer	0.00601	0.0194	CbGeAlD
Adenosine—ADK—female gonad—ovarian cancer	0.00598	0.0193	CbGeAlD
Adenosine—ADK—vagina—ovarian cancer	0.00594	0.0192	CbGeAlD
Adenosine—ADORA2A—testis—ovarian cancer	0.0059	0.019	CbGeAlD
Adenosine—DPP4—female gonad—ovarian cancer	0.0058	0.0187	CbGeAlD
Adenosine—DPP4—vagina—ovarian cancer	0.00576	0.0186	CbGeAlD
Adenosine—ADORA1—vagina—ovarian cancer	0.00571	0.0184	CbGeAlD
Adenosine—ADK—testis—ovarian cancer	0.0053	0.0171	CbGeAlD
Adenosine—DPP4—testis—ovarian cancer	0.00514	0.0166	CbGeAlD
Adenosine—ADORA1—testis—ovarian cancer	0.0051	0.0164	CbGeAlD
Adenosine—ADA—lymph node—ovarian cancer	0.0047	0.0152	CbGeAlD
Adenosine—ADK—lymph node—ovarian cancer	0.00384	0.0124	CbGeAlD
Adenosine—Glucosamine—MMP9—ovarian cancer	0.00382	0.137	CrCbGaD
Adenosine—DPP4—lymph node—ovarian cancer	0.00373	0.012	CbGeAlD
Adenosine—ADORA1—lymph node—ovarian cancer	0.00369	0.0119	CbGeAlD
Adenosine—Adenosine triphosphate—AKT1—ovarian cancer	0.00246	0.0883	CrCbGaD
Adenosine—Chest pain—Melphalan—ovarian cancer	0.0016	0.00317	CcSEcCtD
Adenosine—Ventricular extrasystoles—Epirubicin—ovarian cancer	0.00159	0.00317	CcSEcCtD
Adenosine—Cardiac failure—Docetaxel—ovarian cancer	0.00159	0.00316	CcSEcCtD
Adenosine—Back pain—Vinorelbine—ovarian cancer	0.00158	0.00315	CcSEcCtD
Adenosine—Anaphylactic shock—Topotecan—ovarian cancer	0.00156	0.0031	CcSEcCtD
Adenosine—Anaphylactic shock—Melphalan—ovarian cancer	0.00153	0.00304	CcSEcCtD
Adenosine—Hyperhidrosis—Topotecan—ovarian cancer	0.00151	0.003	CcSEcCtD
Adenosine—Pain—Chlorambucil—ovarian cancer	0.0015	0.00298	CcSEcCtD
Adenosine—Angioedema—Vinorelbine—ovarian cancer	0.0015	0.00297	CcSEcCtD
Adenosine—Tachycardia—Melphalan—ovarian cancer	0.00149	0.00297	CcSEcCtD
Adenosine—Atrioventricular block—Epirubicin—ovarian cancer	0.00149	0.00295	CcSEcCtD
Adenosine—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.00148	0.00293	CcSEcCtD
Adenosine—Pollakiuria—Paclitaxel—ovarian cancer	0.00146	0.0029	CcSEcCtD
Adenosine—Palpitations—Vinorelbine—ovarian cancer	0.00145	0.00288	CcSEcCtD
Adenosine—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00144	0.00286	CcSEcCtD
Adenosine—Injection site reaction—Epirubicin—ovarian cancer	0.00143	0.00285	CcSEcCtD
Adenosine—Hypotension—Melphalan—ovarian cancer	0.00143	0.00284	CcSEcCtD
Adenosine—Cough—Vinorelbine—ovarian cancer	0.00143	0.00284	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00142	0.00283	CcSEcCtD
Adenosine—Hypertension—Vinorelbine—ovarian cancer	0.00141	0.00281	CcSEcCtD
Adenosine—Paraesthesia—Topotecan—ovarian cancer	0.0014	0.00279	CcSEcCtD
Adenosine—Urticaria—Chlorambucil—ovarian cancer	0.00139	0.00277	CcSEcCtD
Adenosine—Chest pain—Vinorelbine—ovarian cancer	0.00139	0.00277	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00139	0.00277	CcSEcCtD
Adenosine—Dyspnoea—Topotecan—ovarian cancer	0.00139	0.00277	CcSEcCtD
Adenosine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00139	0.00276	CcSEcCtD
Adenosine—Myocardial infarction—Paclitaxel—ovarian cancer	0.00138	0.00275	CcSEcCtD
Adenosine—Discomfort—Vinorelbine—ovarian cancer	0.00138	0.00274	CcSEcCtD
Adenosine—Atrioventricular block—Doxorubicin—ovarian cancer	0.00137	0.00273	CcSEcCtD
Adenosine—Paraesthesia—Melphalan—ovarian cancer	0.00137	0.00273	CcSEcCtD
Adenosine—Dyspnoea—Melphalan—ovarian cancer	0.00136	0.00271	CcSEcCtD
Adenosine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00134	0.00266	CcSEcCtD
Adenosine—Pain—Topotecan—ovarian cancer	0.00134	0.00266	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00133	0.00265	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—ovarian cancer	0.00133	0.00263	CcSEcCtD
Adenosine—Bronchospasm—Docetaxel—ovarian cancer	0.00132	0.00262	CcSEcCtD
Adenosine—Pain—Melphalan—ovarian cancer	0.00131	0.0026	CcSEcCtD
Adenosine—Tachycardia—Vinorelbine—ovarian cancer	0.0013	0.00259	CcSEcCtD
Adenosine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00129	0.00257	CcSEcCtD
Adenosine—Bradycardia—Paclitaxel—ovarian cancer	0.00129	0.00256	CcSEcCtD
Adenosine—Asthenia—Chlorambucil—ovarian cancer	0.00126	0.0025	CcSEcCtD
Adenosine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00126	0.0025	CcSEcCtD
Adenosine—Hypotension—Vinorelbine—ovarian cancer	0.00125	0.00248	CcSEcCtD
Adenosine—Urticaria—Topotecan—ovarian cancer	0.00124	0.00247	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00122	0.00242	CcSEcCtD
Adenosine—Urticaria—Melphalan—ovarian cancer	0.00122	0.00242	CcSEcCtD
Adenosine—Paraesthesia—Vinorelbine—ovarian cancer	0.0012	0.00238	CcSEcCtD
Adenosine—Dyspnoea—Vinorelbine—ovarian cancer	0.00119	0.00237	CcSEcCtD
Adenosine—Tinnitus—Paclitaxel—ovarian cancer	0.00118	0.00234	CcSEcCtD
Adenosine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00118	0.00234	CcSEcCtD
Adenosine—Flushing—Paclitaxel—ovarian cancer	0.00117	0.00233	CcSEcCtD
Adenosine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00117	0.00233	CcSEcCtD
Adenosine—Myocardial infarction—Docetaxel—ovarian cancer	0.00117	0.00233	CcSEcCtD
Adenosine—Hypersensitivity—Topotecan—ovarian cancer	0.00115	0.00229	CcSEcCtD
Adenosine—Pain—Vinorelbine—ovarian cancer	0.00114	0.00227	CcSEcCtD
Adenosine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00114	0.00227	CcSEcCtD
Adenosine—Arrhythmia—Paclitaxel—ovarian cancer	0.00113	0.00225	CcSEcCtD
Adenosine—Hypersensitivity—Melphalan—ovarian cancer	0.00113	0.00224	CcSEcCtD
Adenosine—Asthenia—Topotecan—ovarian cancer	0.00112	0.00223	CcSEcCtD
Adenosine—Vomiting—Chlorambucil—ovarian cancer	0.00112	0.00222	CcSEcCtD
Adenosine—Asthenia—Melphalan—ovarian cancer	0.0011	0.00218	CcSEcCtD
Adenosine—Tension—Paclitaxel—ovarian cancer	0.00108	0.00215	CcSEcCtD
Adenosine—Dysgeusia—Paclitaxel—ovarian cancer	0.00108	0.00214	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—ovarian cancer	0.00107	0.00213	CcSEcCtD
Adenosine—Nervousness—Paclitaxel—ovarian cancer	0.00107	0.00213	CcSEcCtD
Adenosine—Hypoaesthesia—Docetaxel—ovarian cancer	0.00107	0.00212	CcSEcCtD
Adenosine—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00107	0.00212	CcSEcCtD
Adenosine—Back pain—Paclitaxel—ovarian cancer	0.00107	0.00212	CcSEcCtD
Adenosine—Urticaria—Vinorelbine—ovarian cancer	0.00106	0.00211	CcSEcCtD
Adenosine—Nausea—Chlorambucil—ovarian cancer	0.00104	0.00207	CcSEcCtD
Adenosine—Vision blurred—Paclitaxel—ovarian cancer	0.00104	0.00206	CcSEcCtD
Adenosine—Dizziness—Topotecan—ovarian cancer	0.00103	0.00205	CcSEcCtD
Adenosine—Tremor—Paclitaxel—ovarian cancer	0.00103	0.00205	CcSEcCtD
Adenosine—Affect lability—Epirubicin—ovarian cancer	0.00103	0.00205	CcSEcCtD
Adenosine—Agitation—Paclitaxel—ovarian cancer	0.00101	0.00201	CcSEcCtD
Adenosine—Angioedema—Paclitaxel—ovarian cancer	0.00101	0.002	CcSEcCtD
Adenosine—Flushing—Docetaxel—ovarian cancer	0.000995	0.00198	CcSEcCtD
Adenosine—Cardiac disorder—Docetaxel—ovarian cancer	0.000995	0.00198	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—ovarian cancer	0.000994	0.00198	CcSEcCtD
Adenosine—Vomiting—Topotecan—ovarian cancer	0.000993	0.00197	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—ovarian cancer	0.000991	0.00197	CcSEcCtD
Adenosine—Mood swings—Epirubicin—ovarian cancer	0.000991	0.00197	CcSEcCtD
Adenosine—Syncope—Paclitaxel—ovarian cancer	0.000988	0.00196	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000987	0.00196	CcSEcCtD
Adenosine—Rash—Topotecan—ovarian cancer	0.000985	0.00196	CcSEcCtD
Adenosine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000985	0.00196	CcSEcCtD
Adenosine—Dermatitis—Topotecan—ovarian cancer	0.000984	0.00196	CcSEcCtD
Adenosine—Headache—Topotecan—ovarian cancer	0.000979	0.00195	CcSEcCtD
Adenosine—Palpitations—Paclitaxel—ovarian cancer	0.000973	0.00193	CcSEcCtD
Adenosine—Vomiting—Melphalan—ovarian cancer	0.000973	0.00193	CcSEcCtD
Adenosine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000968	0.00192	CcSEcCtD
Adenosine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000967	0.00192	CcSEcCtD
Adenosine—Rash—Melphalan—ovarian cancer	0.000965	0.00192	CcSEcCtD
Adenosine—Dermatitis—Melphalan—ovarian cancer	0.000964	0.00192	CcSEcCtD
Adenosine—Cough—Paclitaxel—ovarian cancer	0.000961	0.00191	CcSEcCtD
Adenosine—Asthenia—Vinorelbine—ovarian cancer	0.000959	0.00191	CcSEcCtD
Adenosine—Arrhythmia—Docetaxel—ovarian cancer	0.000958	0.0019	CcSEcCtD
Adenosine—Convulsion—Paclitaxel—ovarian cancer	0.000954	0.0019	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—ovarian cancer	0.000952	0.00189	CcSEcCtD
Adenosine—Hypertension—Paclitaxel—ovarian cancer	0.000951	0.00189	CcSEcCtD
Adenosine—Chest pain—Paclitaxel—ovarian cancer	0.000938	0.00186	CcSEcCtD
Adenosine—Anxiety—Paclitaxel—ovarian cancer	0.000935	0.00186	CcSEcCtD
Adenosine—Nausea—Topotecan—ovarian cancer	0.000928	0.00184	CcSEcCtD
Adenosine—Discomfort—Paclitaxel—ovarian cancer	0.000927	0.00184	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00092	0.00183	CcSEcCtD
Adenosine—Dry mouth—Paclitaxel—ovarian cancer	0.000917	0.00182	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—ovarian cancer	0.000917	0.00182	CcSEcCtD
Adenosine—Dysgeusia—Docetaxel—ovarian cancer	0.000914	0.00182	CcSEcCtD
Adenosine—Nausea—Melphalan—ovarian cancer	0.000909	0.00181	CcSEcCtD
Adenosine—Back pain—Docetaxel—ovarian cancer	0.000903	0.00179	CcSEcCtD
Adenosine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000899	0.00179	CcSEcCtD
Adenosine—Shock—Paclitaxel—ovarian cancer	0.000884	0.00176	CcSEcCtD
Adenosine—Dizziness—Vinorelbine—ovarian cancer	0.000884	0.00176	CcSEcCtD
Adenosine—Tachycardia—Paclitaxel—ovarian cancer	0.000877	0.00174	CcSEcCtD
Adenosine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000869	0.00173	CcSEcCtD
Adenosine—Vomiting—Vinorelbine—ovarian cancer	0.00085	0.00169	CcSEcCtD
Adenosine—Rash—Vinorelbine—ovarian cancer	0.000843	0.00167	CcSEcCtD
Adenosine—Dermatitis—Vinorelbine—ovarian cancer	0.000842	0.00167	CcSEcCtD
Adenosine—Hypotension—Paclitaxel—ovarian cancer	0.00084	0.00167	CcSEcCtD
Adenosine—Headache—Vinorelbine—ovarian cancer	0.000837	0.00166	CcSEcCtD
Adenosine—Syncope—Docetaxel—ovarian cancer	0.000837	0.00166	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—ovarian cancer	0.000835	0.00166	CcSEcCtD
Adenosine—Palpitations—Docetaxel—ovarian cancer	0.000825	0.00164	CcSEcCtD
Adenosine—Loss of consciousness—Docetaxel—ovarian cancer	0.000821	0.00163	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000819	0.00163	CcSEcCtD
Adenosine—Cough—Docetaxel—ovarian cancer	0.000815	0.00162	CcSEcCtD
Adenosine—Convulsion—Docetaxel—ovarian cancer	0.000809	0.00161	CcSEcCtD
Adenosine—Paraesthesia—Paclitaxel—ovarian cancer	0.000807	0.0016	CcSEcCtD
Adenosine—Hypertension—Docetaxel—ovarian cancer	0.000806	0.0016	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—ovarian cancer	0.000806	0.0016	CcSEcCtD
Adenosine—Dyspnoea—Paclitaxel—ovarian cancer	0.000801	0.00159	CcSEcCtD
Adenosine—Somnolence—Paclitaxel—ovarian cancer	0.000799	0.00159	CcSEcCtD
Adenosine—Chest pain—Docetaxel—ovarian cancer	0.000795	0.00158	CcSEcCtD
Adenosine—Nausea—Vinorelbine—ovarian cancer	0.000794	0.00158	CcSEcCtD
Adenosine—Dry mouth—Docetaxel—ovarian cancer	0.000777	0.00154	CcSEcCtD
Adenosine—Sweating—Epirubicin—ovarian cancer	0.000773	0.00154	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—ovarian cancer	0.000773	0.00154	CcSEcCtD
Adenosine—Pain—Paclitaxel—ovarian cancer	0.000769	0.00153	CcSEcCtD
Adenosine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000762	0.00151	CcSEcCtD
Adenosine—Shock—Docetaxel—ovarian cancer	0.00075	0.00149	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—ovarian cancer	0.000746	0.00148	CcSEcCtD
Adenosine—Tachycardia—Docetaxel—ovarian cancer	0.000744	0.00148	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—ovarian cancer	0.000736	0.00146	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—ovarian cancer	0.00072	0.00143	CcSEcCtD
Adenosine—Sweating—Doxorubicin—ovarian cancer	0.000715	0.00142	CcSEcCtD
Adenosine—Urticaria—Paclitaxel—ovarian cancer	0.000714	0.00142	CcSEcCtD
Adenosine—Hypotension—Docetaxel—ovarian cancer	0.000712	0.00141	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000694	0.00138	CcSEcCtD
Adenosine—Paraesthesia—Docetaxel—ovarian cancer	0.000684	0.00136	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—ovarian cancer	0.000681	0.00135	CcSEcCtD
Adenosine—Dyspnoea—Docetaxel—ovarian cancer	0.000679	0.00135	CcSEcCtD
Adenosine—Somnolence—Docetaxel—ovarian cancer	0.000677	0.00135	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—ovarian cancer	0.000675	0.00134	CcSEcCtD
Adenosine—Flushing—Epirubicin—ovarian cancer	0.000671	0.00133	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—ovarian cancer	0.000671	0.00133	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000666	0.00132	CcSEcCtD
Adenosine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000662	0.00132	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000652	0.0013	CcSEcCtD
Adenosine—Pain—Docetaxel—ovarian cancer	0.000652	0.00129	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—ovarian cancer	0.000646	0.00128	CcSEcCtD
Adenosine—Asthenia—Paclitaxel—ovarian cancer	0.000645	0.00128	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—ovarian cancer	0.000624	0.00124	CcSEcCtD
Adenosine—Flushing—Doxorubicin—ovarian cancer	0.000621	0.00123	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000621	0.00123	CcSEcCtD
Adenosine—Tension—Epirubicin—ovarian cancer	0.000618	0.00123	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—ovarian cancer	0.000617	0.00123	CcSEcCtD
Adenosine—Nervousness—Epirubicin—ovarian cancer	0.000612	0.00122	CcSEcCtD
Adenosine—Back pain—Epirubicin—ovarian cancer	0.000609	0.00121	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000603	0.0012	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—ovarian cancer	0.000598	0.00119	CcSEcCtD
Adenosine—Dizziness—Paclitaxel—ovarian cancer	0.000594	0.00118	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—ovarian cancer	0.000594	0.00118	CcSEcCtD
Adenosine—Agitation—Epirubicin—ovarian cancer	0.000579	0.00115	CcSEcCtD
Adenosine—Tension—Doxorubicin—ovarian cancer	0.000572	0.00114	CcSEcCtD
Adenosine—Vomiting—Paclitaxel—ovarian cancer	0.000572	0.00114	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—ovarian cancer	0.000571	0.00113	CcSEcCtD
Adenosine—Rash—Paclitaxel—ovarian cancer	0.000567	0.00113	CcSEcCtD
Adenosine—Dermatitis—Paclitaxel—ovarian cancer	0.000566	0.00113	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—ovarian cancer	0.000566	0.00112	CcSEcCtD
Adenosine—Syncope—Epirubicin—ovarian cancer	0.000565	0.00112	CcSEcCtD
Adenosine—Back pain—Doxorubicin—ovarian cancer	0.000564	0.00112	CcSEcCtD
Adenosine—Headache—Paclitaxel—ovarian cancer	0.000563	0.00112	CcSEcCtD
Adenosine—Hypersensitivity—Docetaxel—ovarian cancer	0.000561	0.00112	CcSEcCtD
Adenosine—Palpitations—Epirubicin—ovarian cancer	0.000557	0.00111	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—ovarian cancer	0.000554	0.0011	CcSEcCtD
Adenosine—Cough—Epirubicin—ovarian cancer	0.00055	0.00109	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—ovarian cancer	0.000549	0.00109	CcSEcCtD
Adenosine—Asthenia—Docetaxel—ovarian cancer	0.000547	0.00109	CcSEcCtD
Adenosine—Convulsion—Epirubicin—ovarian cancer	0.000546	0.00108	CcSEcCtD
Adenosine—Hypertension—Epirubicin—ovarian cancer	0.000544	0.00108	CcSEcCtD
Adenosine—Chest pain—Epirubicin—ovarian cancer	0.000536	0.00107	CcSEcCtD
Adenosine—Agitation—Doxorubicin—ovarian cancer	0.000535	0.00106	CcSEcCtD
Adenosine—Anxiety—Epirubicin—ovarian cancer	0.000534	0.00106	CcSEcCtD
Adenosine—Nausea—Paclitaxel—ovarian cancer	0.000534	0.00106	CcSEcCtD
Adenosine—Discomfort—Epirubicin—ovarian cancer	0.00053	0.00105	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—ovarian cancer	0.000524	0.00104	CcSEcCtD
Adenosine—Syncope—Doxorubicin—ovarian cancer	0.000523	0.00104	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—ovarian cancer	0.000515	0.00102	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000514	0.00102	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000512	0.00102	CcSEcCtD
Adenosine—Cough—Doxorubicin—ovarian cancer	0.000508	0.00101	CcSEcCtD
Adenosine—Shock—Epirubicin—ovarian cancer	0.000506	0.001	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—ovarian cancer	0.000505	0.001	CcSEcCtD
Adenosine—Dizziness—Docetaxel—ovarian cancer	0.000504	0.001	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—ovarian cancer	0.000503	0.001	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—ovarian cancer	0.000502	0.000997	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000497	0.000987	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—ovarian cancer	0.000496	0.000986	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—ovarian cancer	0.000494	0.000982	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—ovarian cancer	0.00049	0.000974	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—ovarian cancer	0.000485	0.000964	CcSEcCtD
Adenosine—Vomiting—Docetaxel—ovarian cancer	0.000484	0.000963	CcSEcCtD
Adenosine—Rash—Docetaxel—ovarian cancer	0.00048	0.000955	CcSEcCtD
Adenosine—Hypotension—Epirubicin—ovarian cancer	0.00048	0.000954	CcSEcCtD
Adenosine—Dermatitis—Docetaxel—ovarian cancer	0.00048	0.000954	CcSEcCtD
Adenosine—Headache—Docetaxel—ovarian cancer	0.000477	0.000949	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000476	0.000945	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000468	0.000931	CcSEcCtD
Adenosine—Shock—Doxorubicin—ovarian cancer	0.000468	0.00093	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—ovarian cancer	0.000464	0.000922	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—ovarian cancer	0.000462	0.000917	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00046	0.000914	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—ovarian cancer	0.000458	0.000911	CcSEcCtD
Adenosine—Somnolence—Epirubicin—ovarian cancer	0.000457	0.000908	CcSEcCtD
Adenosine—Nausea—Docetaxel—ovarian cancer	0.000453	0.000899	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—ovarian cancer	0.000444	0.000883	CcSEcCtD
Adenosine—Pain—Epirubicin—ovarian cancer	0.00044	0.000873	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000433	0.000861	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—ovarian cancer	0.000429	0.0154	CrCbGaD
Adenosine—Paraesthesia—Doxorubicin—ovarian cancer	0.000427	0.000849	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—ovarian cancer	0.000424	0.000843	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—ovarian cancer	0.000423	0.00084	CcSEcCtD
Adenosine—Urticaria—Epirubicin—ovarian cancer	0.000408	0.000811	CcSEcCtD
Adenosine—Pain—Doxorubicin—ovarian cancer	0.000407	0.000808	CcSEcCtD
Adenosine—Hypersensitivity—Epirubicin—ovarian cancer	0.000379	0.000752	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—ovarian cancer	0.000378	0.000751	CcSEcCtD
Adenosine—Asthenia—Epirubicin—ovarian cancer	0.000369	0.000733	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—ovarian cancer	0.00035	0.000696	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—ovarian cancer	0.000341	0.000678	CcSEcCtD
Adenosine—Dizziness—Epirubicin—ovarian cancer	0.00034	0.000675	CcSEcCtD
Adenosine—Vomiting—Epirubicin—ovarian cancer	0.000327	0.000649	CcSEcCtD
Adenosine—Rash—Epirubicin—ovarian cancer	0.000324	0.000644	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—ovarian cancer	0.000324	0.000643	CcSEcCtD
Adenosine—Headache—Epirubicin—ovarian cancer	0.000322	0.00064	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—ovarian cancer	0.000314	0.000625	CcSEcCtD
Adenosine—Nausea—Epirubicin—ovarian cancer	0.000305	0.000607	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—ovarian cancer	0.000302	0.000601	CcSEcCtD
Adenosine—Rash—Doxorubicin—ovarian cancer	0.0003	0.000596	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—ovarian cancer	0.0003	0.000595	CcSEcCtD
Adenosine—Headache—Doxorubicin—ovarian cancer	0.000298	0.000592	CcSEcCtD
Adenosine—Nausea—Doxorubicin—ovarian cancer	0.000282	0.000561	CcSEcCtD
Adenosine—ADK—Metabolism—TYMS—ovarian cancer	0.000229	0.00144	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000227	0.00143	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CD—ovarian cancer	0.000225	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—PTEN—ovarian cancer	0.000224	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—ovarian cancer	0.00022	0.00139	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HDAC6—ovarian cancer	0.000214	0.00135	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000211	0.00133	CbGpPWpGaD
Adenosine—ADA—Metabolism—FASN—ovarian cancer	0.000211	0.00133	CbGpPWpGaD
Adenosine—ADA—Metabolism—SLC5A5—ovarian cancer	0.000208	0.00131	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCL8—ovarian cancer	0.000203	0.00128	CbGpPWpGaD
Adenosine—ADA—Metabolism—SLC2A1—ovarian cancer	0.000201	0.00126	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB2—ovarian cancer	0.000198	0.00125	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—ovarian cancer	0.000198	0.00125	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DOK1—ovarian cancer	0.000197	0.00124	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—ovarian cancer	0.000197	0.00124	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—ovarian cancer	0.000196	0.00124	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CXCL8—ovarian cancer	0.000196	0.00123	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CB—ovarian cancer	0.000196	0.00123	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MTOR—ovarian cancer	0.000196	0.00123	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP1B1—ovarian cancer	0.000192	0.00121	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—YAP1—ovarian cancer	0.00019	0.00119	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—ovarian cancer	0.000188	0.00118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—XIAP—ovarian cancer	0.000186	0.00117	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP1CC—ovarian cancer	0.000186	0.00117	CbGpPWpGaD
Adenosine—ADK—Metabolism—CAV1—ovarian cancer	0.000185	0.00116	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1B—ovarian cancer	0.000184	0.00116	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HDAC6—ovarian cancer	0.000182	0.00115	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—ovarian cancer	0.000181	0.00114	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SMARCA4—ovarian cancer	0.000181	0.00114	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CTNNB1—ovarian cancer	0.000181	0.00114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CASP3—ovarian cancer	0.00018	0.00113	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PPP2R1A—ovarian cancer	0.00018	0.00113	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—ovarian cancer	0.000179	0.00113	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—ovarian cancer	0.000179	0.00113	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EREG—ovarian cancer	0.000177	0.00111	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000175	0.0011	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—ovarian cancer	0.000173	0.00109	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPP2R1A—ovarian cancer	0.000171	0.00108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PTEN—ovarian cancer	0.000169	0.00107	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—ovarian cancer	0.000169	0.00106	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CG—ovarian cancer	0.000168	0.00106	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PGR—ovarian cancer	0.000166	0.00104	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—YAP1—ovarian cancer	0.000161	0.00102	CbGpPWpGaD
Adenosine—ADA—Metabolism—ABCB1—ovarian cancer	0.000158	0.000999	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—XIAP—ovarian cancer	0.000158	0.000995	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000156	0.000982	CbGpPWpGaD
Adenosine—ADA—Metabolism—TYMS—ovarian cancer	0.000156	0.000981	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—ovarian cancer	0.000155	0.000977	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PARP1—ovarian cancer	0.000154	0.00097	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMARCA4—ovarian cancer	0.000154	0.00097	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—ovarian cancer	0.000153	0.000964	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—STAT3—ovarian cancer	0.000151	0.000953	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NRAS—ovarian cancer	0.000151	0.000951	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EREG—ovarian cancer	0.00015	0.000947	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CD—ovarian cancer	0.000148	0.000931	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6ST—ovarian cancer	0.000147	0.000928	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK3—ovarian cancer	0.000145	0.000911	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—ovarian cancer	0.000144	0.000904	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CG—ovarian cancer	0.000141	0.000891	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PGR—ovarian cancer	0.000141	0.000887	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HDAC6—ovarian cancer	0.000141	0.000886	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—ovarian cancer	0.00014	0.000883	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000139	0.000874	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK1—ovarian cancer	0.000138	0.000866	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—ovarian cancer	0.000137	0.000866	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—ovarian cancer	0.000137	0.000866	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000137	0.000863	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—ovarian cancer	0.000133	0.00084	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000132	0.000835	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PARP1—ovarian cancer	0.000131	0.000825	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—ovarian cancer	0.00013	0.000818	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CB—ovarian cancer	0.000129	0.000811	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—ovarian cancer	0.000127	0.000799	CbGpPWpGaD
Adenosine—ADA—Metabolism—CAV1—ovarian cancer	0.000125	0.00079	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6ST—ovarian cancer	0.000125	0.000789	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PPP2R1A—ovarian cancer	0.000125	0.000787	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—YAP1—ovarian cancer	0.000124	0.000784	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CD—ovarian cancer	0.000124	0.000784	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—XIAP—ovarian cancer	0.000122	0.000768	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CG—ovarian cancer	0.00012	0.000758	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000119	0.000752	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—ovarian cancer	0.000119	0.000752	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMARCA4—ovarian cancer	0.000119	0.000749	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000116	0.000734	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EREG—ovarian cancer	0.000116	0.000731	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—ovarian cancer	0.000115	0.000723	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CG—ovarian cancer	0.000114	0.00072	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—ovarian cancer	0.000111	0.000701	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—ovarian cancer	0.00011	0.000696	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—ovarian cancer	0.00011	0.000691	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PGR—ovarian cancer	0.000109	0.000685	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CB—ovarian cancer	0.000108	0.000683	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PPP2R1A—ovarian cancer	0.000106	0.000669	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CD—ovarian cancer	0.000106	0.000666	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—ovarian cancer	0.000106	0.000666	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—ovarian cancer	0.000104	0.000656	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000102	0.000644	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000102	0.00064	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PARP1—ovarian cancer	0.000101	0.000637	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CD—ovarian cancer	0.0001	0.000633	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—ovarian cancer	9.96e-05	0.000627	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TERT—ovarian cancer	9.92e-05	0.000625	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—ovarian cancer	9.75e-05	0.000615	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—ovarian cancer	9.75e-05	0.000614	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6ST—ovarian cancer	9.67e-05	0.000609	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—ovarian cancer	9.32e-05	0.000587	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CG—ovarian cancer	9.29e-05	0.000585	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CB—ovarian cancer	9.22e-05	0.000581	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CAV1—ovarian cancer	9.18e-05	0.000578	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CD—ovarian cancer	8.99e-05	0.000567	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—ovarian cancer	8.86e-05	0.000558	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—ovarian cancer	8.84e-05	0.000557	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CB—ovarian cancer	8.75e-05	0.000552	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6ST—ovarian cancer	8.7e-05	0.000548	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—ovarian cancer	8.47e-05	0.000533	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TERT—ovarian cancer	8.43e-05	0.000531	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CG—ovarian cancer	8.36e-05	0.000527	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APC—ovarian cancer	8.36e-05	0.000527	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—NRAS—ovarian cancer	8.36e-05	0.000527	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP2R1A—ovarian cancer	8.2e-05	0.000516	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CD—ovarian cancer	8.17e-05	0.000514	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK3—ovarian cancer	8e-05	0.000504	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—ovarian cancer	7.85e-05	0.000495	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	7.84e-05	0.000494	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CAV1—ovarian cancer	7.8e-05	0.000492	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK1—ovarian cancer	7.62e-05	0.00048	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—ovarian cancer	7.61e-05	0.00048	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—ovarian cancer	7.56e-05	0.000477	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—ovarian cancer	7.53e-05	0.000475	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—ovarian cancer	7.52e-05	0.000474	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6ST—ovarian cancer	7.4e-05	0.000466	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CD—ovarian cancer	7.35e-05	0.000463	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—ovarian cancer	7.28e-05	0.000459	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—ovarian cancer	7.2e-05	0.000453	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—ovarian cancer	7.19e-05	0.000453	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CB—ovarian cancer	7.12e-05	0.000448	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CG—ovarian cancer	7.11e-05	0.000448	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APC—ovarian cancer	7.11e-05	0.000448	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—NRAS—ovarian cancer	7.11e-05	0.000448	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—ovarian cancer	6.84e-05	0.000431	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK3—ovarian cancer	6.81e-05	0.000429	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—ovarian cancer	6.61e-05	0.000416	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—ovarian cancer	6.54e-05	0.000412	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TERT—ovarian cancer	6.51e-05	0.00041	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—ovarian cancer	6.49e-05	0.000409	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK1—ovarian cancer	6.48e-05	0.000408	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—ovarian cancer	6.47e-05	0.000408	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—ovarian cancer	6.41e-05	0.000404	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MTOR—ovarian cancer	6.4e-05	0.000403	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CB—ovarian cancer	6.4e-05	0.000403	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CD—ovarian cancer	6.25e-05	0.000394	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—ovarian cancer	6.19e-05	0.00039	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—ovarian cancer	6.15e-05	0.000388	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—ovarian cancer	6.12e-05	0.000385	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—ovarian cancer	6.11e-05	0.000385	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CAV1—ovarian cancer	6.02e-05	0.00038	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1B—ovarian cancer	6.01e-05	0.000379	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—ovarian cancer	5.94e-05	0.000375	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—ovarian cancer	5.89e-05	0.000371	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—ovarian cancer	5.88e-05	0.000371	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—ovarian cancer	5.85e-05	0.000369	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—ovarian cancer	5.8e-05	0.000366	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—ovarian cancer	5.73e-05	0.000361	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6ST—ovarian cancer	5.71e-05	0.00036	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNB1—ovarian cancer	5.68e-05	0.000358	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—ovarian cancer	5.62e-05	0.000354	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—ovarian cancer	5.57e-05	0.000351	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—ovarian cancer	5.53e-05	0.000349	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—ovarian cancer	5.52e-05	0.000348	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APC—ovarian cancer	5.49e-05	0.000346	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CG—ovarian cancer	5.49e-05	0.000346	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—NRAS—ovarian cancer	5.49e-05	0.000346	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CB—ovarian cancer	5.45e-05	0.000343	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MTOR—ovarian cancer	5.45e-05	0.000343	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—ovarian cancer	5.4e-05	0.00034	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—ovarian cancer	5.34e-05	0.000336	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK3—ovarian cancer	5.25e-05	0.000331	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—ovarian cancer	5.23e-05	0.00033	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—ovarian cancer	5.2e-05	0.000328	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1B—ovarian cancer	5.11e-05	0.000322	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—ovarian cancer	5.05e-05	0.000318	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—ovarian cancer	5.01e-05	0.000316	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—ovarian cancer	5e-05	0.000315	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK1—ovarian cancer	5e-05	0.000315	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—ovarian cancer	5e-05	0.000315	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—ovarian cancer	5e-05	0.000315	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—ovarian cancer	4.98e-05	0.000314	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—ovarian cancer	4.95e-05	0.000312	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NRAS—ovarian cancer	4.94e-05	0.000311	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—ovarian cancer	4.87e-05	0.000307	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNB1—ovarian cancer	4.83e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CD—ovarian cancer	4.82e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	4.78e-05	0.000301	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—ovarian cancer	4.73e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK3—ovarian cancer	4.73e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—ovarian cancer	4.72e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—ovarian cancer	4.71e-05	0.000296	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—ovarian cancer	4.6e-05	0.00029	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—ovarian cancer	4.59e-05	0.000289	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK1—ovarian cancer	4.5e-05	0.000283	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—ovarian cancer	4.5e-05	0.000283	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—ovarian cancer	4.36e-05	0.000275	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—ovarian cancer	4.34e-05	0.000273	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—ovarian cancer	4.26e-05	0.000268	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—ovarian cancer	4.25e-05	0.000268	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—ovarian cancer	4.25e-05	0.000268	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—ovarian cancer	4.21e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CB—ovarian cancer	4.2e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTOR—ovarian cancer	4.2e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NRAS—ovarian cancer	4.2e-05	0.000264	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—ovarian cancer	4.04e-05	0.000255	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK3—ovarian cancer	4.02e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—ovarian cancer	4.01e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1B—ovarian cancer	3.95e-05	0.000249	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—ovarian cancer	3.91e-05	0.000246	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—ovarian cancer	3.9e-05	0.000246	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—ovarian cancer	3.9e-05	0.000246	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—ovarian cancer	3.87e-05	0.000244	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—ovarian cancer	3.86e-05	0.000243	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—ovarian cancer	3.84e-05	0.000242	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK1—ovarian cancer	3.83e-05	0.000241	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—ovarian cancer	3.82e-05	0.000241	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—ovarian cancer	3.78e-05	0.000238	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—ovarian cancer	3.76e-05	0.000237	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNB1—ovarian cancer	3.73e-05	0.000235	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—ovarian cancer	3.65e-05	0.00023	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—ovarian cancer	3.63e-05	0.000229	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—ovarian cancer	3.61e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—ovarian cancer	3.61e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—ovarian cancer	3.54e-05	0.000223	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—ovarian cancer	3.46e-05	0.000218	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—ovarian cancer	3.32e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—ovarian cancer	3.28e-05	0.000207	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—ovarian cancer	3.25e-05	0.000205	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRAS—ovarian cancer	3.24e-05	0.000204	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—ovarian cancer	3.21e-05	0.000202	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—ovarian cancer	3.19e-05	0.000201	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK3—ovarian cancer	3.1e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—ovarian cancer	3.07e-05	0.000193	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—ovarian cancer	3.02e-05	0.00019	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK1—ovarian cancer	2.95e-05	0.000186	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—ovarian cancer	2.95e-05	0.000186	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—ovarian cancer	2.94e-05	0.000185	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—ovarian cancer	2.79e-05	0.000176	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—ovarian cancer	2.71e-05	0.000171	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—ovarian cancer	2.56e-05	0.000161	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—ovarian cancer	2.48e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—ovarian cancer	2.37e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—ovarian cancer	2.27e-05	0.000143	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—ovarian cancer	2.09e-05	0.000132	CbGpPWpGaD
